Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 10, 2018

Performance evaluation of a new automated fourth-generation HIV Ag/Ab combination chemiluminescence immunoassay

  • Yanhua Zhao , Yu Gou , Dongdong Li , Tingting Wang , Xiyue Huang , Mingqiao Shi and Chuanmin Tao EMAIL logo

Acknowledgments

We thank Fujirebio Incorporation for providing the Lumipulse® HIV Ag/Ab assay. We also acknowledge other colleagues who took part in the routine detection but do not become authors.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the Health and Family Planning Commission of Sichuan Province, under Grant no. (2017)70.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Gisslen M, Svedhem V, Lindborg L, Flamholc L, Norrgren H, Wendahl S, et al. Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets. HIV Med 2017;18:305–7.10.1111/hiv.12431Search in Google Scholar PubMed PubMed Central

2. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 2009;49:1570–8.10.1086/644772Search in Google Scholar PubMed PubMed Central

3. Muhlbacher A, Schennach H, van Helden J, Hebell T, Pantaleo G, Burgisser P, et al. Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay. Med Microbiol Immunol 2013;202:77–86.10.1007/s00430-012-0250-5Search in Google Scholar PubMed PubMed Central

4. Tao CM, Cho Y, Ng KP, Han X, Oh EJ, Zainah S, et al. Validation of the Elecsys® HIV combi PT assay for screening and reliable early detection of HIV-1 infection in Asia. J Clin Virol 2013;58:221–6.10.1016/j.jcv.2013.05.012Search in Google Scholar PubMed

5. Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods; approved guideline-second edition. CLSI document EP5-A2. Wayne, PA: CSLI, 2004.Search in Google Scholar

6. Centers for Disease Control and Prevention. Laboratory testing for the diagnosis of HIV infection: updated recommendations (2014). Available at: https://stacks.cdc.gov/view/cdc/23447. Accessed: 27 Jun 2014.Search in Google Scholar

7. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. The challenge of HIV-1 subtype diversity. N Engl J Med 2008;358:1590–602.10.1056/NEJMra0706737Search in Google Scholar PubMed PubMed Central

8. Qiu X, Sokoll L, Yip P, Elliott DJ, Dua R, Mohr P, et al. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens. J Clin Virol 2017;92:62–8.10.1016/j.jcv.2017.05.005Search in Google Scholar PubMed

9. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871–9.10.1097/00002030-200309050-00005Search in Google Scholar PubMed

Received: 2017-10-9
Accepted: 2017-10-23
Published Online: 2018-1-10
Published in Print: 2018-4-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 20.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2017-0910/html
Scroll to top button